146 related articles for article (PubMed ID: 38063282)
21. Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996.
Schneider JS; Moore DH; Mendelsohn ML
J Am Acad Dermatol; 2008 May; 58(5):741-9. PubMed ID: 18068264
[TBL] [Abstract][Full Text] [Related]
22. Incidence and Mortality of Malignant Melanoma in Relation to Dermatologist Density in Bavaria.
Drexler K; Drexler H; Geissler EK; Berneburg M; Haferkamp S; Apfelbacher C
Adv Ther; 2021 Nov; 38(11):5548-5556. PubMed ID: 34596866
[TBL] [Abstract][Full Text] [Related]
23. Screening for skin cancer.
Helfand M; Mahon SM; Eden KB; Frame PS; Orleans CT
Am J Prev Med; 2001 Apr; 20(3 Suppl):47-58. PubMed ID: 11306232
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of skin cancer screening for individuals age 14 to 34 years.
Schmitt J; Seidler A; Heinisch G; Sebastian G
J Dtsch Dermatol Ges; 2011 Aug; 9(8):608-16. PubMed ID: 21501381
[TBL] [Abstract][Full Text] [Related]
25. [Malignant melanoma of the skin: does screening for cancer influence the incidence and mortality?].
Schubert A
Gesundheitswesen; 2012 Mar; 74(3):154-9. PubMed ID: 21305450
[TBL] [Abstract][Full Text] [Related]
26. The effect of screening on melanoma incidence and biopsy rates.
Whiteman DC; Olsen CM; MacGregor S; Law MH; Thompson B; Dusingize JC; Green AC; Neale RE; Pandeya N;
Br J Dermatol; 2022 Oct; 187(4):515-522. PubMed ID: 35531668
[TBL] [Abstract][Full Text] [Related]
27. [Screening for and early detection of skin melanoma in the Netherlands].
van Roekel EH; Verbeek AL; Bonenkamp H
Ned Tijdschr Geneeskd; 2012; 156(26):A4456. PubMed ID: 22759708
[TBL] [Abstract][Full Text] [Related]
28. [Skin cancer screening in Germany: review after ten years].
Hübner J; Eisemann N; Brunßen A; Katalinic A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Dec; 61(12):1536-1543. PubMed ID: 30411137
[TBL] [Abstract][Full Text] [Related]
29. Does skin cancer screening save lives?: an observational study comparing trends in melanoma mortality in regions with and without screening.
Katalinic A; Waldmann A; Weinstock MA; Geller AC; Eisemann N; Greinert R; Volkmer B; Breitbart E
Cancer; 2012 Nov; 118(21):5395-402. PubMed ID: 22517033
[TBL] [Abstract][Full Text] [Related]
30. Effects of the German skin cancer screening programme on melanoma incidence and indicators of disease severity.
Trautmann F; Meier F; Seidler A; Schmitt J
Br J Dermatol; 2016 Nov; 175(5):912-919. PubMed ID: 27203791
[TBL] [Abstract][Full Text] [Related]
31. Opportunistic screening strategy for cutaneous melanoma does not change the incidence of nodular and thick lesions nor reduce mortality: a population-based descriptive study in the European region with the highest incidence.
Bordoni A; Leoni-Parvex S; Peverelli S; Mazzola P; Mazzucchelli L; Spitale A
Melanoma Res; 2013 Oct; 23(5):402-7. PubMed ID: 23839077
[TBL] [Abstract][Full Text] [Related]
32. Serial screening for melanoma: measures and strategies that have consistently achieved early detection and cure.
Shore RN; Shore P; Monahan NM; Sundeen J
J Drugs Dermatol; 2011 Mar; 10(3):244-52. PubMed ID: 21369639
[TBL] [Abstract][Full Text] [Related]
33. Association between risk factors and detection of cutaneous melanoma in the setting of a population-based skin cancer screening.
Hübner J; Waldmann A; Eisemann N; Noftz M; Geller AC; Weinstock MA; Volkmer B; Greinert R; Breitbart EW; Katalinic A
Eur J Cancer Prev; 2018 Nov; 27(6):563-569. PubMed ID: 28692584
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program.
Koh HK; Norton LA; Geller AC; Sun T; Rigel DS; Miller DR; Sikes RG; Vigeland K; Bachenberg EU; Menon PA; Billon SF; Goldberg G; Scarborough DA; Ramsdell WM; Muscarella VA; Lew RA
J Am Acad Dermatol; 1996 Jun; 34(6):971-8. PubMed ID: 8647990
[TBL] [Abstract][Full Text] [Related]
35. Screening for melanoma in aging patients.
Wolf J; Harris R; Ferris LK
Cutis; 2013 Feb; 91(2):81-6. PubMed ID: 23513556
[TBL] [Abstract][Full Text] [Related]
36. Skin biopsy rates and incidence of melanoma: population based ecological study.
Welch HG; Woloshin S; Schwartz LM
BMJ; 2005 Sep; 331(7515):481. PubMed ID: 16081427
[TBL] [Abstract][Full Text] [Related]
37. Five-Year Outcomes of a Melanoma Screening Initiative in a Large Health Care System.
Matsumoto M; Wack S; Weinstock MA; Geller A; Wang H; Solano FX; Kirkwood JM; Ferris LK
JAMA Dermatol; 2022 May; 158(5):504-512. PubMed ID: 35385051
[TBL] [Abstract][Full Text] [Related]
38. A Large Skin Cancer Screening Quality Initiative: Description and First-Year Outcomes.
Ferris LK; Saul MI; Lin Y; Ding F; Weinstock MA; Geller AC; Yuan JM; Neuren E; Maddukuri S; Solano FX; Kirkwood JM
JAMA Oncol; 2017 Aug; 3(8):1112-1115. PubMed ID: 28241191
[TBL] [Abstract][Full Text] [Related]
39. Screening and early detection of skin cancer.
Linden KG
Curr Oncol Rep; 2004 Nov; 6(6):491-6. PubMed ID: 15485620
[TBL] [Abstract][Full Text] [Related]
40. Are patients benefiting from participation in the German skin cancer screening programme? A large cohort study based on administrative data.
Datzmann T; Schoffer O; Meier F; Seidler A; Schmitt J
Br J Dermatol; 2022 Jan; 186(1):69-77. PubMed ID: 34289097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
